| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Medicus Pharma Ltd.
13G/A
Amendment 2
MDCX · 58471K301
|
3.6% |
10/16/2026
Event 9/30/2026
|
|||
| Melani Kenneth R. | 3.6% | ||||
| Velocity Fund Partners, LP | 3.2% | ||||
|
Medicus Pharma Ltd.
13G/A
Amendment 1
MDCX · 58471K202
|
18.2% |
8/12/2025
Event 6/30/2025
|
|||
| Melani Kenneth R. | 18.2% | ||||
| Velocity Fund Partners, LP | 15.9% | ||||
|
Medicus Pharma Ltd.
13G
MDCX · 58471K202
|
28.1% |
2/13/2025
Event 12/31/2024
|
|||
| Melani Kenneth R. | 28.1% | ||||
| Velocity Fund Partners, LP | 24.7% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.